Compare $ACUT vs $KAPA | Chartloom

Compare

$ACUT vs $KAPA

Accustem Sciences Inc · Kairos Pharma Ltd

ACUT

Accustem Sciences Inc

KAPA

Kairos Pharma Ltd

Compare $ACUT vs $KAPA

Comparing Accustem Sciences Inc and Kairos Pharma Ltd

ACUTAccustem Sciences Inc

KAPAKairos Pharma Ltd

ACUTAccustem Sciences Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.6%

52W performance

-67.3%

FCF yield

-50.9%

KAPAKairos Pharma Ltd

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-84.1%

52W performance

-91.2%

FCF yield

-22.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACUT

KAPA

Detailed metrics comparison

ACUT

Accustem Sciences Inc

KAPA

Kairos Pharma Ltd

Market Cap

ACUT$2M

KAPA$17M

Enterprise Value

ACUT$2M

KAPA$15M

Price

ACUT$0.15

KAPA$0.81

P/E Ratio

ACUTN/A

KAPAN/A

P/S Ratio

ACUT0.00x

KAPA0.00x

EV/Sales

ACUT0.00x

KAPA0.00x

EV/EBITDA

ACUT0.00x

KAPA0.00x

P/B Ratio

ACUT2.97x

KAPA1.26x

P/FCF Ratio

ACUTN/A

KAPAN/A

EV/FCF

ACUT-2.01x

KAPA-3.71x

PEG Ratio

ACUTN/A

KAPAN/A

Forward P/E (NTM)

ACUTN/A

KAPAN/A

Forward P/S (NTM)

ACUTN/A

KAPAN/A

Revenue (TTM)

ACUT$0

KAPA$0

Revenue Growth (YoY)

ACUTN/A

KAPAN/A

Forward Rev Growth

ACUT0.0%

KAPA0.0%

Gross Margin (TTM)

ACUT0.0%

KAPA0.0%

Operating Margin (TTM)

ACUT0.0%

KAPA0.0%

EBITDA Margin (TTM)

ACUT0.0%

KAPA0.0%

Net Margin (TTM)

ACUT0.0%

KAPA0.0%

FCF Margin (TTM)

ACUTN/A

KAPAN/A

Net Income (TTM)

ACUT$-2M

KAPA$-6M

FCF (TTM)

ACUT$-1M

KAPA$-4M

EPS (TTM)

ACUT-$0.10

KAPA-$0.27

ROE (TTM)

ACUT-21712.9%

KAPA-9877.0%

ROA (TTM)

ACUT-10530.0%

KAPA-9361.0%

ROIC (TTM)

ACUT-179413.5%

KAPA-9877.0%

Cash

ACUT$13K

KAPA$3M

Debt

ACUT$63K

KAPA$0

Net Cash/Debt

ACUT$-50K

KAPA$3M

Current Ratio (TTM)

ACUT0.02x

KAPA11.98x

Quick Ratio (TTM)

ACUT0.00x

KAPA11.46x

Debt/Equity (TTM)

ACUT0.27x

KAPA0.00x

Debt/Assets (TTM)

ACUT0.0%

KAPA0.0%

Interest Coverage (TTM)

ACUTN/A

KAPAN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

KAPA0.00x

Beta

ACUT1.88

KAPA3.30

52W Performance

ACUT-67.3%

KAPA-91.2%

YTD Performance

ACUT-75.6%

KAPA-84.1%

% from 52W High

ACUT-93.7%

KAPA-91.6%

% from 52W Low

ACUT26.0%

KAPA3.5%

Asset Turnover (TTM)

ACUT0.00x

KAPA0.00x

FCF Yield (TTM)

ACUT-50.9%

KAPA-22.9%

Earnings Yield (TTM)

ACUT-69.8%

KAPA-33.5%

Dividend Yield (TTM)

ACUTN/A

KAPAN/A

Rule of 40

ACUT0.0

KAPA0.0

EV/GP/RG

ACUTN/A

KAPAN/A

Ticker research

View ACUT research View KAPA research

Metric	ACUT Accustem Sciences Inc	KAPA Kairos Pharma Ltd
Market & Valuation
Market Cap	$2M	$17M
Enterprise Value	$2M	$15M
Price	$0.15	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.97x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-3.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-2M	$-6M
FCF (TTM)	$-1M	$-4M
EPS (TTM)	-$0.10	-$0.27
ROE (TTM)	-21712.9%	-9877.0%
ROA (TTM)	-10530.0%	-9361.0%
ROIC (TTM)	-179413.5%	-9877.0%
Financial Health
Cash	$13K	$3M
Debt	$63K	$0
Net Cash/Debt	$-50K	$3M
Current Ratio (TTM)	0.02x	11.98x
Quick Ratio (TTM)	0.00x	11.46x
Debt/Equity (TTM)	0.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	3.30
52W Performance	-67.3%	-91.2%
YTD Performance	-75.6%	-84.1%
% from 52W High	-93.7%	-91.6%
% from 52W Low	26.0%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-50.9%	-22.9%
Earnings Yield (TTM)	-69.8%	-33.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACUT research	View KAPA research

Valuation

P/S Ratio

ACUT

0.00x

KAPA

0.00x

EV/FCF

KAPA

-3.71x

ACUT

-2.01x

Growth & revenue

Forward Revenue Growth

ACUT

0.0%

KAPA

0.0%

Profitability & performance

Gross Margin

ACUT

0.0%

KAPA

0.0%

ROE

KAPA

-9877.0%

ACUT

-21712.9%

FCF Yield %

KAPA

-22.9%

ACUT

-50.9%

52-Week Performance

ACUT

-67.3%

KAPA

-91.2%

Detailed metrics comparison

ACUT

Accustem Sciences Inc

KAPA

Kairos Pharma Ltd

Market Cap

ACUT$2M

KAPA$17M

Enterprise Value

ACUT$2M

KAPA$15M

Price

ACUT$0.15

KAPA$0.81

P/E Ratio

ACUTN/A

KAPAN/A

P/S Ratio

ACUT0.00x

KAPA0.00x

EV/Sales

ACUT0.00x

KAPA0.00x

EV/EBITDA

ACUT0.00x

KAPA0.00x

P/B Ratio

ACUT2.97x

KAPA1.26x

P/FCF Ratio

ACUTN/A

KAPAN/A

EV/FCF

ACUT-2.01x

KAPA-3.71x

PEG Ratio

ACUTN/A

KAPAN/A

Forward P/E (NTM)

ACUTN/A

KAPAN/A

Forward P/S (NTM)

ACUTN/A

KAPAN/A

Revenue (TTM)

ACUT$0

KAPA$0

Revenue Growth (YoY)

ACUTN/A

KAPAN/A

Forward Rev Growth

ACUT0.0%

KAPA0.0%

Gross Margin (TTM)

ACUT0.0%

KAPA0.0%

Operating Margin (TTM)

ACUT0.0%

KAPA0.0%

EBITDA Margin (TTM)

ACUT0.0%

KAPA0.0%

Net Margin (TTM)

ACUT0.0%

KAPA0.0%

FCF Margin (TTM)

ACUTN/A

KAPAN/A

Net Income (TTM)

ACUT$-2M

KAPA$-6M

FCF (TTM)

ACUT$-1M

KAPA$-4M

EPS (TTM)

ACUT-$0.10

KAPA-$0.27

ROE (TTM)

ACUT-21712.9%

KAPA-9877.0%

ROA (TTM)

ACUT-10530.0%

KAPA-9361.0%

ROIC (TTM)

ACUT-179413.5%

KAPA-9877.0%

Cash

ACUT$13K

KAPA$3M

Debt

ACUT$63K

KAPA$0

Net Cash/Debt

ACUT$-50K

KAPA$3M

Current Ratio (TTM)

ACUT0.02x

KAPA11.98x

Quick Ratio (TTM)

ACUT0.00x

KAPA11.46x

Debt/Equity (TTM)

ACUT0.27x

KAPA0.00x

Debt/Assets (TTM)

ACUT0.0%

KAPA0.0%

Interest Coverage (TTM)

ACUTN/A

KAPAN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

KAPA0.00x

Beta

ACUT1.88

KAPA3.30

52W Performance

ACUT-67.3%

KAPA-91.2%

YTD Performance

ACUT-75.6%

KAPA-84.1%

% from 52W High

ACUT-93.7%

KAPA-91.6%

% from 52W Low

ACUT26.0%

KAPA3.5%

Asset Turnover (TTM)

ACUT0.00x

KAPA0.00x

FCF Yield (TTM)

ACUT-50.9%

KAPA-22.9%

Earnings Yield (TTM)

ACUT-69.8%

KAPA-33.5%

Dividend Yield (TTM)

ACUTN/A

KAPAN/A

Rule of 40

ACUT0.0

KAPA0.0

EV/GP/RG

ACUTN/A

KAPAN/A

Ticker research

View ACUT research View KAPA research

Metric	ACUT Accustem Sciences Inc	KAPA Kairos Pharma Ltd
Market & Valuation
Market Cap	$2M	$17M
Enterprise Value	$2M	$15M
Price	$0.15	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.97x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-3.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-2M	$-6M
FCF (TTM)	$-1M	$-4M
EPS (TTM)	-$0.10	-$0.27
ROE (TTM)	-21712.9%	-9877.0%
ROA (TTM)	-10530.0%	-9361.0%
ROIC (TTM)	-179413.5%	-9877.0%
Financial Health
Cash	$13K	$3M
Debt	$63K	$0
Net Cash/Debt	$-50K	$3M
Current Ratio (TTM)	0.02x	11.98x
Quick Ratio (TTM)	0.00x	11.46x
Debt/Equity (TTM)	0.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	3.30
52W Performance	-67.3%	-91.2%
YTD Performance	-75.6%	-84.1%
% from 52W High	-93.7%	-91.6%
% from 52W Low	26.0%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-50.9%	-22.9%
Earnings Yield (TTM)	-69.8%	-33.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACUT research	View KAPA research